Your session is about to expire
← Back to Search
Telementoring Intervention for Diagnostic Imaging Clinicians
N/A
Waitlist Available
Led By Eduardo Bruera
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights
Study Summary
This trial is testing how well the ECHO telementoring intervention works in transforming professional engagement, practice efficiency, and community building through team meetings in diagnostic imaging clinicians.
Who is the study for?
This trial is for diagnostic imaging clinicians at MD Anderson without leadership roles and who haven't been in an ECHO clinic before. It's focused on those looking to improve engagement, efficiency, and community through team meetings.Check my eligibility
What is being tested?
The study tests the ECHO telementoring intervention's effectiveness in enhancing professional interaction, work efficiency, and community among physicians across different locations using team meetings.See study design
What are the potential side effects?
Since this isn't a drug trial but an educational intervention involving questionnaires and communication strategies, there are no medical side effects. Participants may experience changes in work patterns or stress levels.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Proportion of sessions attended
Side effects data
From 2020 Phase 3 trial • 177 Patients • NCT0181707513%
Rash maculo-papular
10%
Skin and subcutaneous tissue disorders - Other, specify
1%
Mucositis oral
1%
Sepsis
1%
Skin ulceration
1%
Urticaria
100%
80%
60%
40%
20%
0%
Study treatment Arm
Arm I (CHG Cleansing Wipe)
Arm II (Control)
Trial Design
2Treatment groups
Experimental Treatment
Group I: Arm B (wait-list, ECHO telementoring)Experimental Treatment3 Interventions
Participants are placed on a wait-list for 13 weeks and then attend ECHO telementoring sessions over 1 hour weekly for 13 weeks.
Group II: Arm A (ECHO telementoring)Experimental Treatment2 Interventions
Participants attend ECHO telementoring sessions over 1 hour weekly for 13 weeks.
Find a Location
Who is running the clinical trial?
M.D. Anderson Cancer CenterLead Sponsor
2,966 Previous Clinical Trials
1,804,745 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,933,117 Total Patients Enrolled
1 Trials studying Blood Cancers
70 Patients Enrolled for Blood Cancers
Eduardo BrueraPrincipal InvestigatorM.D. Anderson Cancer Center
3 Previous Clinical Trials
294 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Arm B (wait-list, ECHO telementoring)
- Group 2: Arm A (ECHO telementoring)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any vacancies for this medical experiment?
"According to the data available on clinicaltrials.gov, this medical study is not recruiting at present. The initial listing was posted on August 16th 2020 and last updated May 26th 2022; however, there are presently 2426 other trials actively seeking participants."
Answered by AI
Share this study with friends
Copy Link
Messenger